Comprehensive Genomic Profiling With Loss of Heterozygosity for Ovarian Cancer Treatment

June 16, 2017
Julia Elvin, MD, PhD

Julia Elvin, MD, PhD, vice president and senior associate medical director, Foundation Medicine, discusses a study of comprehensive genomic profiling with loss of heterozygosity to identify therapeutically relevant subsets of ovarian cancer.